Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo.
about
Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cellsEpstein-Barr virus infection is not a characteristic feature of multiple sclerosis brainDefining the directionality and quality of influenza virus-specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virusViral immune evasion due to persistence of activated T cells without effector functionPhase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosisSpecificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopesDetection and characterization of cellular immune responses using peptide-MHC microarraysAntigen-specific cytometryMHC class I multimersProlonged activation of virus-specific CD8+T cells after acute B19 infection.Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen- or tumour-derived synthetic peptidesEvolution of the immune system in humans from infancy to old ageEpstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developmentsSerological diagnosis of Epstein-Barr virus infection: Problems and solutionsThe interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and diseaseT cell memory in the context of persistent herpes viral infectionsTherapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinomaEpstein-Barr virus infection and posttransplant lymphoproliferative disorderAntiviral T-cell therapyAdoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized miceSustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C VirusFull-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy.Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramersCross-Reactive T-Cell Responses to the Nonstructural Regions of Dengue Viruses among Dengue Fever and Dengue Hemorrhagic Fever Patients in MalaysiaQuantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramersRapid Determination of HLA B*07 Ligands from the West Nile Virus NY99 GenomeComparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 ResponsivenessAnalysis of successful immune responses in persons infected with hepatitis C virusNK Cell Influence on the Outcome of Primary Epstein-Barr Virus InfectionInfectious mononucleosis.Host-reactive CD8+ memory stem cells in graft-versus-host diseaseProgrammed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usageIncomplete CD8(+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigenBeyond 51Cr release: New methods for assessing HIV-1-specific CD8+ T cell responses in peripheral blood and mucosal tissues.Virus-specific CD8(+) T cells with type 1 or type 2 cytokine profile are related to different disease activity in chronic hepatitis C virus infection.Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells.Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation.The role of cytokines which signal through the common gamma chain cytokine receptor in the reversal of HIV specific CD4(+) and CD8(+) T cell anergyAnalytical performance of a standardized single-platform MHC tetramer assay for the identification and enumeration of CMV-specific CD8+ T lymphocytes.Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka.
P2860
Q24290869-384C9CDB-9702-4339-B650-BF4C00747916Q24642187-FE6CCB8F-0226-4BC6-BFFF-0FE1E2A7693EQ24645078-D84F0C93-D2F5-4AD1-98C9-1AD0706E4283Q24646943-BCE806EC-A232-423E-A599-3E2D892F6FD5Q24657081-B3F385FA-5E16-43CD-9066-DE984959A51DQ24792319-161CF7B7-42FC-44FF-904B-023917ED8854Q24800142-12777DFE-E67A-4E45-9E52-6D4DFCB676EAQ24804980-8A8F08CA-A2AA-42FD-9E2E-3F44D39C1740Q24805668-061E124E-72B2-4522-9F11-E3513F8BCE17Q24811737-FA7B1979-CEBF-4385-9A2A-F7AC95CD8044Q25257170-C3AF314E-A2B2-4F2D-8AD0-B5517CED1D60Q26772107-783BFBAD-14DC-4196-86D9-D5DC1E2F5C9DQ26775442-D26C9D43-61CC-41C3-A767-F2EB4633DD67Q26829346-BF82BD49-8FE5-461A-8E9E-01367F52C132Q26998401-CB5E244B-4BBF-4E99-AAA6-9DE9FD92B577Q26999125-FD2F2EE5-E2C9-467F-A7F5-206205884681Q27016002-A9109CC4-E0D8-4E53-93B6-656834F1FFD1Q27024229-E3748303-5466-49A0-8243-789C75DB7A02Q27028006-C60E770B-642D-4608-994E-0B9C5A44EA19Q27324235-ACDA0899-2707-4411-97F9-5410D0DF1D16Q27469800-68216CF0-66D1-40CC-88C7-BA508038E489Q27472170-23C23D2D-A054-40B9-8F02-0ECA66613DBFQ27477753-0D3669DA-E55B-43D5-9F80-F67ADEAF562EQ27481431-DAD52BF9-16DD-441F-BACB-B754D605C09AQ27485114-BE8D2B0A-419E-43FE-8EFF-09DDCF56866EQ27487800-E52E3B5C-D070-4D4C-90E5-9F0A59939885Q27487966-DA3CC4ED-D0FC-4FC9-90BD-F8F013F27B1AQ27860698-154CFFEF-33CF-4A45-97CB-D79EAA31F134Q28069456-31325FA4-F4AF-4D62-B689-8C6EC6C7163DQ28084340-F271E55C-4F6A-44EA-A9FB-EA37BB13AE57Q28281894-B8DE5E33-6C49-44C9-83F6-0D333AAA4932Q28749172-61743AD5-5233-4783-ADE9-4202D263C1B9Q30305658-B2587EDD-3F56-4327-A657-197BDB662751Q30332080-5B727DF1-EEE9-4205-AC05-C019430C5FE7Q32159849-3B2C0F7B-5436-4C8E-AFEB-D038C8362D57Q33181641-9AB64227-A4F7-424E-9CC0-6173A3196E24Q33182059-902A8B04-873D-4768-9560-25E24104D938Q33279519-60A63D66-F741-4C37-AA17-DFC1C69150A8Q33369455-DAEDA08D-1ED7-41F6-9A3E-849E44EFD850Q33386017-42D4FBC9-15AD-4A71-AC0D-90E0DEFCE857
P2860
Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Direct visualization of antige ...... to Epstein-Barr virus In vivo.
@en
type
label
Direct visualization of antige ...... to Epstein-Barr virus In vivo.
@en
prefLabel
Direct visualization of antige ...... to Epstein-Barr virus In vivo.
@en
P2093
P2860
P356
P1476
Direct visualization of antige ...... to Epstein-Barr virus In vivo.
@en
P2093
McMichael AJ
O'Callaghan CA
Rickinson AB
P2860
P304
P356
10.1084/JEM.187.9.1395
P407
P577
1998-05-01T00:00:00Z